JUE CHEN received the Bachelor of Medicine degree in preventive medicine and the master's degree in toxicology from Fudan University, Shanghai, China, in 2001 and 2004, respectively, and the Ph.D. degree in pharmacology from Emory University in 2011. She joined the Laboratory of Biochemistry, Intramural Program, National Heart, Lung, and Blood Institute (NHLBI). In 2015, she then joined the NHLBI extramural program as a Program Officer with the Division of Cardiovascular Sciences (DCVS). Dr. Chen's past research experience includes the investigation of car- diotoxicity of environmental and occupational cadmium exposure, understanding the role of an antioxidative response enzyme in the pathogenesis of Parkinson's disease, and determining the biological functions of redox signaling mediated by methionine oxidation and reduction. She currently manages basic and preclinical research grants studying atherosclerosis in the Atherothrombosis and Coronary Artery Disease Branch of the DCVS in the NHLBI.
JTEHM, Articles, Published ArticlesPoint-of-Care Technologies for the Advancement of Precision Medicine in Heart, Lung, Blood, and Sleep Disorders
Mary Emma Gorham Bigelow, Brian G. Jamieson, Chi On Chui, Yufei Mao, Kyeong-Sik Shin, Tony Jun Huang, Po-Hsun Huang, Liqiang Ren, Bishow Adhikari, Jue Chen, Erin Iturriaga
A discussion of the importance of point-of-care (POC) technologies in facilitating precision medicine for heart, lung, blood, and sleep disorders, including three such technologies currently undergoing commercialization. The commercialization of new point of care technologies holds great potential in facilitating and... Read more
Posted on 8 AUG 2016